Advertisement

Statistical evaluation and positive predictive value of key features of periorbital basal cell carcinoma

Published:August 28, 2022DOI:https://doi.org/10.1016/j.jcjo.2022.07.015

      Abstract

      Objective

      To determine the accuracy of using the suspicious features of periorbital lesions—telangiectasias, madarosis, and ulceration—to identify basal cell carcinoma (BCC). This may impact whether a histopathologic confirmation is always necessary.

      Methods

      This retrospective review of patients who underwent biopsy of eyelid lesions was conducted over a five-year period, between 2015 and 2020 at a single clinical site. Specifically, the histopathologic diagnosis and the presence or absence of clinical signs of madarosis, ulceration and telangiectasia were recorded. The positive predictive value (PPV) for eyelid BCC and odds ratio of each of these clinical signs was calculated.

      Results

      179 patients underwent incisional biopsies of eye lid lesions. Of the 79 patients with eyelid BCC, 96% had ulceration, 95% had madarosis, and 75% had telangiectasias over the lid lesion; this contrasted with the 3%, 4% and 6% respectively in the 100 patients with benign lid lesions. The PPV for eyelid BCC of ulceration was 95.0%, madarosis was 96.2% and telangiectasias was 90.8%. The presence of two or all three signs in a patient was strongly predictive of BCC (PPV=100%).

      Conclusion

      The presence of two or more suspicious features almost ensures the accuracy of the suspected diagnosis of a BCC. This suggests that biopsy of eyelid lesions before complete surgical excision that demonstrate several defining features may not be necessary in all cases. However, lesions that do not demonstrate multiple explicit features that indicate a malignancy will still require histopathologic confirmation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Shi Y
        • Jia R
        • Fan X.
        Ocular basal cell carcinoma: A brief literature review of clinical diagnosis and treatment.
        Onco Targets Ther. 2017; 10: 2483-2489https://doi.org/10.2147/OTT.S130371
        • Bichakjian C
        • Armstrong A
        • Baum C
        • et al.
        Guidelines of care for the management of basal cell carcinoma.
        J Am Acad Dermatol. 2018; 78: 540-559https://doi.org/10.1016/j.jaad.2017.10.006
        • Margo CE
        • Waltz K.
        Basal cell carcinoma of the eyelid and periocular skin.
        Surv Ophthalmol. 1993; 38: 169-192https://doi.org/10.1016/0039-6257(93)90100-L
        • Allali J
        • D'Hermies F
        • Renard G
        Basal cell carcinomas of the eyelids.
        Ophthalmologica. 2005; 219: 57-71https://doi.org/10.1159/000083263
        • Parichehr K
        • Farideh D
        • Amirhossein R
        • Ahmad S-A
        • Mohammad E-A
        • Mansour M.
        Assessment of clinical diagnostic accuracy compared with pathological diagnosis of basal cell carcinoma.
        Indian Dermatol Online J. 2015; 6: 258https://doi.org/10.4103/2229-5178.160257
        • Bhatnagar A
        • Mohamad S
        • Sandramouli S.
        Fast-tracking” cancer referrals: Application for periocular basal cell carcinoma.
        Eye. 2006; 20: 428-430https://doi.org/10.1038/sj.eye.6701894
        • Rossato LA
        • Carneiro RC
        • Miyazaki A
        • Matayoshi S.
        Accuracy of clinical examination in the diagnosis of eyelid lesions.
        Rev Bras Oftalmol. 2014; 73: 324-328https://doi.org/10.5935/0034-7280.20140069
        • Kersten RC
        • Ewing-Chow D
        • Kulwin DR
        • Gallon M.
        Accuracy of clinical diagnosis of cutaneous eyelid lesions.
        Ophthalmology. 1997; 104: 479-484https://doi.org/10.1016/S0161-6420(97)30288-7
        • Ahnlide I
        • Bjellerup M.
        Accuracy of clinical skin tumour diagnosis in a dermatological setting.
        Acta Derm Venereol. 2013; 93: 305-308https://doi.org/10.2340/00015555-1560
      1. Popadić M. Statistical evaluation of dermoscopic features in basal cell carcinomas. Dermatologic Surg. 2014;40(7):718-724. doi: 10.1111/dsu.0000000000000031.

        • Williams NM
        • Navarrete-Dechent C
        • Marghoob AA
        • Abarzua-Araya Á
        • Salerni G
        • Jaimes N.
        Differentiating basal cell carcinoma from intradermal nevi along the eyelid margin with dermoscopy: A case series.
        J Am Acad Dermatol. 2021; 84: 173-175https://doi.org/10.1016/j.jaad.2020.04.059
        • Margo CE.
        Eyelid tumors: Accuracy of clinical diagnosis.
        Am J Ophthalmol. 1999; 128: 635-636https://doi.org/10.1016/S0002-9394(99)00302-5
        • Reiter O
        • Mimouni I
        • Gdalevich M
        • Marghoob AA
        • Levi A
        • Hodak E
        • Leshem YA.
        The diagnostic accuracy of dermoscopy for basal cell carcinoma: A systematic review and meta-analysis.
        J Am Acad Dermatol. 2019; 80: 1380-1388https://doi.org/10.1016/j.jaad.2018.12.026